NCT03510104 2026-01-08Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid TumorsMeryx, Inc.Phase 1 Completed42 enrolled
NCT07162883 2025-09-09Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)Qilu Pharmaceutical Co., Ltd.Phase 3 Not yet recruiting122 enrolled
NCT04601584 2024-03-06GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLAO GENERIUMPhase 1/2 Recruiting36 enrolled
NCT04373265 2024-02-23Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)Corcept TherapeuticsPhase 1 Completed15 enrolled
NCT02130557 2021-05-18A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaPfizerPhase 3 Completed536 enrolled 24 charts 1 FDA
NCT01201811 2019-12-05Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)CelgenePhase 4 Completed44 enrolled 26 charts
NCT01386580 2015-01-22An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.BBB-Therapeutics B.V.Phase 1/2 Completed84 enrolled
NCT00969410 2012-04-12A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver MetastasesAVEO Pharmaceuticals, Inc.Phase 1 Completed19 enrolled
NCT00692159 2010-09-10Study of TRC102 in Combination With Pemetrexed in Cancer PatientsTracon Pharmaceuticals Inc.Phase 1 Completed28 enrolled